Sign in

10x Genomics, Inc.

Income Statement - 10x Genomics, Inc. (TXG)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.64 0.61 0.62 0.52 0.49 0.30 0.25 0.15 0.07
Cost of revenue 0.20 0.20 0.21 0.12 0.07 0.06 0.06 0.03 0.01
Gross profit 0.44 0.41 0.41 0.40 0.42 0.24 0.18 0.12 0.06
Total operating expenses + 0.55 0.61 0.67 0.56 0.47 0.33 0.21 0.14 0.08
Operating income -0.11 -0.19 -0.27 -0.17 -0.05 -0.09 -0.03 -0.11 -0.02
Non-operating income (net) 0.07 0.02 0.02 0.01 0.00 -0.45 0.00 0.00 0.00
Income before tax -0.04 -0.18 -0.25 -0.16 -0.05 -0.53 -0.03 -0.11 -0.02
Income tax expense 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00
Net income -0.04 -0.18 -0.26 -0.17 -0.06 -0.54 -0.03 -0.11 -0.02
Show Quarterly Income Statement

Income Statement - 10x Genomics, Inc. (TXG)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.15 0.17 0.15 0.17 0.15 0.17 0.15 0.15 0.14 0.18 0.15 0.15 0.13 0.16 0.13 0.11 0.11 0.14 0.13 0.12 0.11 0.11 0.07 0.04 0.07 0.08 0.06 0.06 0.05 0.05 0.04 0.03 0.03
Cost of revenue 0.04 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.07 0.06 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.00 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.00 0.00
Gross profit 0.11 0.11 0.10 0.13 0.11 0.11 0.11 0.10 0.09 0.12 0.10 0.10 0.10 0.12 0.10 0.09 0.09 0.12 0.10 0.11 0.09 0.09 0.06 0.03 0.06 0.06 0.05 0.04 0.04 0.04 0.03 0.03 0.03
Total operating expenses + 0.12 0.13 0.13 0.09 0.14 0.16 0.15 0.15 0.15 0.17 0.19 0.16 0.15 0.14 0.14 0.15 0.13 0.13 0.12 0.12 0.10 0.50 0.12 0.07 0.08 0.07 0.05 0.05 0.04 0.04 0.03 0.03 0.04
Operating income -0.02 -0.02 -0.03 0.03 -0.04 -0.05 -0.04 -0.04 -0.06 -0.06 -0.09 -0.06 -0.05 -0.02 -0.04 -0.06 -0.04 -0.02 -0.02 -0.01 -0.01 -0.41 -0.07 -0.04 -0.02 -0.01 -0.01 -0.01 0.00 -0.07 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.01 -0.02 -0.03 0.04 -0.03 -0.05 -0.03 -0.04 -0.06 -0.05 -0.09 -0.06 -0.05 -0.02 -0.04 -0.06 -0.04 -0.02 -0.02 -0.01 -0.01 -0.41 -0.07 -0.04 -0.02 -0.01 -0.01 -0.01 0.00 -0.08 -0.02 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.01 -0.02 -0.03 0.03 -0.03 -0.05 -0.04 -0.04 -0.06 -0.05 -0.09 -0.06 -0.05 -0.02 -0.04 -0.06 -0.04 -0.02 -0.02 -0.01 -0.01 -0.42 -0.07 -0.04 -0.02 -0.01 -0.01 -0.01 0.00 -0.08 -0.02 -0.01 -0.01
4 days ago

Balance Sheet - 10x Genomics, Inc. (TXG)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.52 0.39 0.39 0.43 0.59 0.66 0.42 0.07 0.05
Accounts receivable, net 0.08 0.09 0.11 0.10 0.09 0.05 0.03 0.03 0.01
Inventories 0.06 0.08 0.07 0.08 0.06 0.03 0.02 0.01 0.00
Other current assets 0.02 0.02 0.02 0.02 0.01 0.03 0.01 0.00 0.00
Total current assets 0.68 0.58 0.60 0.64 0.75 0.77 0.48 0.11 0.07
Total non-current assets + 0.36 0.33 0.37 0.39 0.27 0.15 0.13 0.02 0.01
Total assets 1.04 0.92 0.97 1.03 1.02 0.93 0.61 0.12 0.08
Total current liabilities + 0.15 0.12 0.13 0.13 0.11 0.12 0.06 0.03 0.02
Total non-current liabilities + 0.09 0.09 0.10 0.09 0.09 0.07 0.12 0.31 0.17
Total liabilities 0.25 0.21 0.22 0.22 0.20 0.19 0.19 0.34 0.19
Total stockholders' equity + 0.80 0.71 0.74 0.81 0.82 0.74 0.42 -0.22 -0.11
Common shares outstanding 125 120 117 114 110 101 78 13 12
Show Quarterly Balance Sheet

Balance Sheet - 10x Genomics, Inc. (TXG)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 0.54 0.52 0.48 0.45 0.43 0.39 0.40 0.38 0.37 0.39 0.36 0.39 0.42 0.43 0.45 0.50 0.54 0.59 0.60 0.62 0.62 0.66 0.77 0.34 0.37 0.42 0.43 0.06 0.07 0.07 0.07 0.00 0.05
Accounts receivable, net 0.06 0.08 0.10 0.12 0.05 0.09 0.08 0.09 0.09 0.11 0.10 0.09 0.08 0.10 0.08 0.08 0.08 0.09 0.08 0.06 0.06 0.05 0.04 0.02 0.03 0.03 0.03 0.03 0.00 0.03 0.03
Inventories 0.05 0.06 0.06 0.07 0.07 0.08 0.09 0.09 0.08 0.07 0.08 0.08 0.08 0.08 0.08 0.07 0.06 0.06 0.05 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.00 0.01 0.01
Other current assets 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.03 0.03 0.03 0.07 0.07 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.67 0.68 0.66 0.66 0.58 0.58 0.59 0.58 0.57 0.60 0.56 0.58 0.60 0.64 0.63 0.67 0.70 0.75 0.74 0.76 0.75 0.77 0.90 0.45 0.43 0.48 0.47 0.11 0.07 0.11 0.11 0.05
Total non-current assets + 0.35 0.36 0.37 0.32 0.32 0.33 0.34 0.35 0.36 0.37 0.39 0.41 0.41 0.39 0.37 0.34 0.31 0.27 0.25 0.22 0.21 0.15 0.14 0.13 0.18 0.13 0.10 0.05 -0.07 0.02 0.00 -0.05
Total assets 1.02 1.04 1.03 0.98 0.90 0.92 0.94 0.93 0.92 0.97 0.95 0.99 1.01 1.03 1.00 1.00 1.00 1.02 0.99 0.98 0.95 0.93 1.04 0.58 0.61 0.61 0.57 0.16 0.00 0.12 0.12
Total current liabilities + 0.11 0.15 0.15 0.11 0.11 0.12 0.12 0.11 0.11 0.13 0.10 0.10 0.11 0.13 0.13 0.12 0.09 0.11 0.10 0.11 0.12 0.12 0.15 0.12 0.06 0.06 0.05 0.04 0.00 0.03 0.03
Total non-current liabilities + 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.10 0.10 0.10 0.10 0.10 0.09 0.09 0.10 0.10 0.09 0.09 0.08 0.08 0.07 0.07 0.07 0.14 0.12 0.10 0.10 0.00 0.31 0.00
Total liabilities 0.20 0.25 0.24 0.21 0.20 0.21 0.21 0.21 0.20 0.22 0.20 0.20 0.21 0.22 0.22 0.22 0.20 0.20 0.19 0.19 0.20 0.19 0.22 0.19 0.20 0.19 0.15 0.14 0.00 0.34 0.10
Total stockholders' equity + 0.81 0.80 0.79 0.77 0.71 0.71 0.72 0.72 0.72 0.74 0.75 0.79 0.80 0.81 0.78 0.78 0.81 0.82 0.80 0.78 0.75 0.74 0.83 0.39 0.41 0.42 0.42 0.02 0.02 -0.22 -0.22 0.05
Common shares outstanding 128 127 126 125 123 122 121 120 119 119 118 117 116 115 114 114 113 112 111 110 109 107 101 99 97 96 88 16 15 14 14 78 78
4 days ago

Cash Flow - 10x Genomics, Inc. (TXG)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + 0.14 0.01 -0.02 -0.03 -0.02 -0.22 0.03 -0.08 -0.01
Cash flow from investing + -0.01 -0.03 0.13 -0.35 -0.11 -0.04 -0.04 -0.01 0.00
Cash flow from financing + 0.01 0.01 0.01 0.02 0.04 0.47 0.41 0.11 0.02
Change in cash 0.13 -0.02 0.13 -0.37 -0.09 0.21 0.41 0.02 0.01
Change in exchange rate 0.00 0.00
Show Quarterly Cash Flow

Cash Flow - 10x Genomics, Inc. (TXG)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + 0.03 0.04 0.04 0.02 0.03 -0.01 0.02 0.01 -0.02 0.03 -0.03 -0.01 0.00 0.01 -0.01 -0.02 -0.02 0.01 -0.03 0.00 0.00 -0.13 -0.06 -0.03 0.00 0.01 0.01 0.00 0.01 -0.05 -0.01 -0.01 -0.01
Cash flow from investing + 0.00 0.00 -0.01 0.00 0.00 -0.05 0.00 0.01 0.01 0.01 0.00 0.00 0.12 -0.03 -0.03 -0.03 -0.26 -0.03 -0.02 -0.01 -0.04 -0.02 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Cash flow from financing + -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.01 0.02 0.00 0.01 0.49 0.01 -0.03 0.00 0.42 0.00 0.00 0.04 0.00 0.03 0.03
Change in cash 0.02 0.04 0.04 0.02 0.03 -0.05 0.02 0.02 0.00 0.04 -0.02 -0.01 0.11 -0.01 -0.04 -0.04 -0.28 -0.01 -0.04 0.00 -0.04 -0.14 0.43 -0.03 -0.04 0.00 0.42 -0.01 0.00 -0.02 -0.01 0.02 0.02
Change in exchange rate 0.00 0.00 0.00 0.00
4 days ago

10x Genomics, Inc. (TXG) - Capital Expenditures

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Change In Exchange Rate

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Dividend Payout

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Net Income

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Stock Based Compensation

1Y 2Y 5Y Max
8 days ago

10x Genomics, Inc. (TXG) - Cashflow From Financing

1Y 2Y 5Y Max
8 days ago